Squarepoint
OPRX icon

Squarepoint’s OptimizeRx OPRX Stock Holding History

Squarepoint’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$448K Buy
53,684
+8,620
+19% +$62.2K ﹤0.01% 3471
2026
Q2 		$258K Sell
45,064
-132,507
-75% -$762K ﹤0.01% 3922
2026
Q1 		$1.12M Sell
177,571
-29,390
-14% -$273K ﹤0.01% 2684
2025
Q4 		$2.54M Buy
206,961
+67,884
+49% +$1.11M ﹤0.01% 1896
2025
Q3 		$2.85M Buy
+139,077
New +$2.21M ﹤0.01% 1826
2025
Q2 		– Sell
-10,746
Closed -$93.1K – 4900
2025
Q1 		$93.1K Sell
10,746
-30,966
-74% -$189K ﹤0.01% 4237
2024
Q4 		$203K Buy
41,712
+31,252
+299% +$175K ﹤0.01% 4465
2024
Q3 		$80.8K Sell
10,460
-17,693
-63% -$157K ﹤0.01% 3916
2024
Q2 		$282K Buy
+28,153
New +$309K ﹤0.01% 3465
2024
Q1 		– Sell
-30,971
Closed -$443K – 4442
2023
Q4 		$443K Buy
30,971
+17,230
+125% +$165K ﹤0.01% 3094
2023
Q3 		$107K Sell
13,741
-9,595
-41% -$104K ﹤0.01% 3551
2023
Q2 		$333K Buy
+23,336
New +$332K ﹤0.01% 2900
2023
Q1 		– Sell
-20,116
Closed -$338K – 3636
2022
Q4 		$338K Sell
20,116
-4,460
-18% -$77.1K ﹤0.01% 2507
2022
Q3 		$364K Buy
+24,576
New +$486K ﹤0.01% 2379
2022
Q2 		– Sell
-30,366
Closed -$1.14M – 3234
2022
Q1 		$1.14M Buy
30,366
+5,788
+24% +$256K ﹤0.01% 1500
2021
Q4 		$1.53M Buy
+24,578
New +$1.86M ﹤0.01% 1419
2021
Q3 		– Sell
-7,320
Closed -$453K – 3280
2021
Q2 		$453K Buy
+7,320
New +$373K ﹤0.01% 2218
2020
Q3 		– Sell
-29,490
Closed -$384K – 2743
2020
Q2 		$384K Buy
+29,490
New +$321K 0.01% 1451
2019
Q4 		– Sell
-27,000
Closed -$391K – 2715
2019
Q3 		$391K Buy
27,000
+5,400
+25% +$83.6K ﹤0.01% 1744
2019
Q2 		$350K Buy
+21,600
New +$292K ﹤0.01% 1857

Other funds holding OPRX

Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
McAdam LLC
McAdam LLC Philadelphia, Pennsylvania $2.66B AUM 14.82% 1-Year Est. Return
Merit Financial Group
Merit Financial Group Alpharetta, Georgia $17.9B AUM 18.85% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Squarepoint's OPRX Position: Q3 2026 in Review

Squarepoint increased its OptimizeRx (OPRX) stake by 19% in Q3 2026, buying an estimated $62.2K and bringing the position to 53,684 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

Squarepoint first reported a position in OPRX in Q2 2019 and has held it in 20 quarters since. The position peaked at $2.85M in Q3 2025. 37 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.

  • Squarepoint held 53,684 shares of OptimizeRx worth $448K as of Q3 2026.
  • Squarepoint bought 8,620 OptimizeRx shares in Q3 2026, an estimated $62.2K.
  • OptimizeRx made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3471 holding.
  • Squarepoint first reported a position in OptimizeRx in Q2 2019 and has held it in 20 quarters since.
  • Squarepoint's OptimizeRx position peaked at $2.85M in Q3 2025.
  • 37 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.